Ep195: Ken Song on T-cell Engagers for Autoimmune Diseases
Podcast: The Long Run with Luke TimmermanPublished On: Tue Mar 03 2026
Description: Ken Song, CEO of San Diego-based Candid Therapeutics, on developing bispecific T-cell engaging antibodies for autoimmune disease.
The note was deleted
The note was saved
Your message was sent